Link has appointed Marc Lemaître as chairman of the board. He takes over from Mick McLean, who is stepping down after nine years in the role. Lemaître currently works as an independent consultant, although he joined Link in 2015 as a non-executive director. He has also worked for Glen Research and served as CEO of Grindus America.
Wave Life Sciences has appointed Keith Regnante as its CFO. Regnante comes to Wave from Shire, where he served as vice president of finance. Prior to Shire, he held a number of positions of increasing responsibility at Biogen. Earlier in his career, Regnante worked as a consultant with the Boston Consulting Group.
Good Start Genetics has appointed James Frontero as chief commercial officer. Before joining Good Start, Frontero served as senior vice president of sales and commercial operations at Devicor Medical Products. Prior to his work at Devicor, he served as president of Straumann USA and held numerous sales and sales leadership roles within Boston Scientific.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.